349 related articles for article (PubMed ID: 17689760)
1. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
2. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
3. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
5. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
7. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
Thomson R; Eccles M; Wood R; Chinn DJ
Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
[TBL] [Abstract][Full Text] [Related]
8. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
Inoue H; Nozawa T; Okumura K; Jong-Dae L; Shimizu A; Yano K
Chest; 2004 Sep; 126(3):687-92. PubMed ID: 15364743
[TBL] [Abstract][Full Text] [Related]
9. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?
Zimetbaum PJ; Thosani A; Yu HT; Xiong Y; Lin J; Kothawala P; Emons M
Am J Med; 2010 May; 123(5):446-53. PubMed ID: 20399322
[TBL] [Abstract][Full Text] [Related]
10. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):685-9. PubMed ID: 9307554
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
13. Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice.
Laguna P; Martín A; Del Arco C; Millán I; Gargantilla P;
Acad Emerg Med; 2005 Sep; 12(9):828-34. PubMed ID: 16141016
[TBL] [Abstract][Full Text] [Related]
14. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
[TBL] [Abstract][Full Text] [Related]
15. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
Lopes RD; Starr A; Pieper CF; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Mahaffey KW; Armstrong PW; Harrington RA; White HD; Wallentin L; Granger CB
Am J Med; 2010 Feb; 123(2):134-40. PubMed ID: 20103022
[TBL] [Abstract][Full Text] [Related]
16. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
[TBL] [Abstract][Full Text] [Related]
17. [Incidence and risk factors of stroke in patients with nonvalvular atrial fibrillation in Haikou].
Zeng M; Wu ZY; Zheng Y; Chen J; Feng GQ; Fu XH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):905-8. PubMed ID: 19950611
[TBL] [Abstract][Full Text] [Related]
18. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH
Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
